Lv22
140 积分 2024-09-24 加入
From TCR fundamental research to innovative chimeric antigen receptor design
5天前
已完结
Preclinical studies show that Co-STARs combine the advantages of chimeric antigen and T cell receptors for the treatment of tumors with low antigen densities
5天前
已完结
Development of Antibiotic-Free Selection System for Safer DNA Vaccination
6天前
已完结
Transgelin 2 guards T cell lipid metabolism and antitumour function
8天前
已完结
A roadmap for affordable genetic medicines
18天前
已完结
In vivo CAR T cells move into clinical trials
1个月前
已完结
皖公网安备34019202002308
